Preferences for adjuvant immunotherapy in patients with resected stage III melanoma: A discrete choice experiment.

被引：0
|
作者：
Livingstone, Ann
Menzies, Alexander M.
Howard, Kirsten
Stockler, Martin R.
Morton, Rachael L.
机构：
[1] Univ Sydney, Sydney, NSW, Australia
[2] Univ Sydney, Melanoma Inst Australia, Sydney, NSW, Australia
[3] Royal North Shore & Mater Hosp, Sydney, NSW, Australia
[4] Univ Sydney, NHMRC Clin Trials Ctr, Sydney, NSW, Australia
[5] Univ Sydney, Melanoma Inst Australia, NHMRC Clin Trials Ctr, Sydney, NSW, Australia
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
基金：
英国医学研究理事会;
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9556
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Preferences for Adjuvant Immunotherapy in Adults with Resected Stage III Melanoma—A Discrete Choice Experiment
    Ann Livingstone
    Kirsten Howard
    Alexander M. Menzies
    Georgina V. Long
    Martin R. Stockler
    Rachael L. Morton
    [J]. The Patient - Patient-Centered Outcomes Research, 2023, 16 : 497 - 513
  • [2] Preferences for Adjuvant Immunotherapy in Adults with Resected Stage III Melanoma-A Discrete Choice Experiment
    Livingstone, Ann
    Howard, Kirsten
    Menzies, Alexander M.
    Long, Georgina V.
    Stockler, Martin R.
    Morton, Rachael L.
    [J]. PATIENT-PATIENT CENTERED OUTCOMES RESEARCH, 2023, 16 (05): : 497 - 513
  • [3] Management of resected stage III/IV melanoma with adjuvant immunotherapy.
    Johnson, Rebecca
    Atkinson, Victoria
    Bhave, Prachi
    Weppler, Alison Margaret
    Peters, Geoffrey David
    Abed, Afaf
    Lyle, Megan
    Khattak, Muhammad Adnan
    Haydon, Andrew Mark
    Carlino, Matteo S.
    Sandhu, Shahneen Kaur
    Long, Georgina V.
    Menzies, Alexander M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [4] Patient Preferences in Adjuvant and Palliative Treatment of Advanced Melanoma: A Discrete Choice Experiment
    Weilandt, Juliane
    Diehl, Katharina
    Schaarschmidt, Marthe-Lisa
    Kiecker, Felix
    Sasama, Bianca
    Pronk, Melanie
    Ohletz, Jan
    Koennecke, Andreas
    Mueller, Verena
    Utikal, Jochen
    Hillen, Uwe
    Harth, Wolfgang
    Peitsch, Wiebke K.
    [J]. ACTA DERMATO-VENEREOLOGICA, 2020, 100 (03) : 1 - 9
  • [5] Adjuvant Pembrolizumab in Resected Stage III Melanoma
    Barker, Christopher A.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (06): : 593 - 593
  • [6] Patient and physician preferences for adjuvant treatment of renal cell carcinoma: A discrete-choice experiment.
    Calhoun, Shawna R.
    Vass, Caroline
    Myers, Kelley
    Imai, Kentaro
    Bussberg, Cooper
    Bhattacharya, Rituparna
    Pinto, Cathy Anne
    Poulos, Christine
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [7] PATIENTS' PREFERENCES FOR PSORIASIS TREATMENT BASED ON A DISCRETE CHOICE EXPERIMENT. COEPSO STUDY
    Llamas-Velasco, M.
    Sanchez-Perez, J.
    Pardo, J.
    Cabeza-Martinez, R.
    Miranda Fontes, M.
    Marquez, J.
    Armesto, S.
    Belinchon, I
    Castaneda, S.
    Casado, A.
    Amaro, A.
    Yebenes, M.
    Sabater, E.
    [J]. VALUE IN HEALTH, 2018, 21 : S471 - S472
  • [8] Adjuvant immunotherapy with tumor infiltrating lymphocytes and interleukin-2 in patients with resected stage III and IV melanoma
    Ridolfi, L
    Ridolfi, R
    Riccobon, A
    De Paola, F
    Petrini, M
    Stefanelli, M
    Flamini, E
    Ravaioli, A
    Verdecchia, GM
    Trevisan, G
    Amadori, D
    [J]. JOURNAL OF IMMUNOTHERAPY, 2003, 26 (02): : 156 - 162
  • [9] Impact of adjuvant immunotherapy on survival of patients with resected stage III melanoma diagnosed in 2003-2011 in the US
    Jang, S.
    Wang, H.
    Venna, S.
    [J]. MELANOMA RESEARCH, 2016, 26 : E8 - E9
  • [10] Impact of adjuvant immunotherapy in resected stage II/III/IV melanoma: A single center experience
    Sevillano Tripero, Alberto Rafael
    Ortiz, Carolina
    Lostes, Julia
    Bodet, Domingo
    Ferrandiz, Carla
    Bassas, Patricia
    Chiquillo, Paula
    Villacampa, Guillermo
    Vega-Cano, Kreina Sharela
    Garcia-Patos, Vicente
    Recio, Juan
    Munoz-Couselo, Eva
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
12345